|
|
|
|
|
|
| ||||
Last Loaded on Web: Thursday, May 01, 2008
EMBASE AlertTM is a current awareness pharmacological and biomedical literature database renowned for its coverage of the drug-related literature. It is updated weekly and contains the most recent 8 weeks' worth of data, and on average contains approximately 80,000 records. It is made up of bibliographic records that have not yet been indexed by the EMBASE editors. Most records consist of bibliographic citations containing abstracts and author-supplied keywords.
EMBASE Alert is not cumulative, but rather a "rolling" file; as a new update is added each week, the oldest week is deleted. Citations can be found with full indexing in EMBASETM (File 72) just a few weeks following their appearance in EMBASE Alert.
Citations from more than 5,000 journals from about 70 countries are included.
USE FILE 172to search for the very latest biomedical and pharmaceutical articles; use it together with EMBASE (Files 72 and 73) for both current and comprehensive information. USE FREE TEXT SEARCHINGin the Basic Index since the records include no controlled subject indexing. USE LIMITSto restrict search results to English (/ENG) or to records containing abstracts (/ABS). |
| Dates Covered: | Current 8 weeks |
|---|---|
| File Size: | Approximately 80,000 records |
| Update Frequency: | Daily |
| ACRONYM | CATEGORY NAME |
|---|---|
| ALTMED | Alternative Medicine |
| BIOCHEM | Biochemistry |
| BIOSCI | Biosciences |
| BIOTECH | Biotechnology |
| HEALTH | Health |
| MEDDEV | Medical Devices |
| MEDENG | Medical Engineering |
| MEDICINE | Medicine |
| NUTRIT | Nutrition |
| PHARM | Pharmacology |
| PHARMR | Pharmacology + RINGDOC-Files |
| SAFETY | Safety |
| TOXICOL | Toxicology |
|
Elsevier B.V. P.O. Box 211 Amsterdam, 1000 AE The Netherlands
|
For Dialog's Redistribution and Archive Policy, enter HELP ERA online. Note, however, that Embase Alert has a separate Archive policy and data may only be held in electronic form for a maximum period of 12 months from the date it is first downloaded and must then be deleted. Those customers that want to archive beyond 12 months should contact their Account Manager or nearest Customer Services desk to obtain an extended archiving license. The following terms and conditions also apply.
The database is owned and copyrighted by Elsevier B.V. NEITHER ELSEVIER NOR ANY OF ITS AFFILIATES OR LICENSORS SHALL BE LIABLE TO YOU OR ANYONE ELSE FOR ANY LOSS OR INJURY, CAUSED IN WHOLE OR PART BY ITS NEGLIGENCE OR CONTINGENCIES BEYOND ITS CONTROL IN PROCURING, COMPILING, INTERPRETING, REPORTING, OR DELIVERING INFORMATION THROUGH THE SITE. IN NO EVENT WILL ELSEVIER, ITS AFFILIATES OR LICENSORS BE LIABLE TO YOU OR ANYONE ELSE FOR ANY DECISION MADE OR ACTION TAKEN BY YOU IN RELIANCE ON SUCH INFORMATION. ELSEVIER AND ITS AFFILIATES AND LICENSORS SHALL NOT BE LIABLE TO YOU OR ANYONE ELSE FOR ANY DAMAGES (INCLUDING, WITHOUT LIMITATION, CONSEQUENTIAL, SPECIAL, INCIDENTAL, INDIRECT, OR SIMILAR DAMAGES) EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
Elsevier neither endorses nor takes responsibility for any products, goods or services offered by outside vendors through our services or advertised on our system.
| DIALOG(R)File 172:EMBASE ALERT | |
| (Copr. 1995). ELSEVIER B.V. All rts. reserv. | |
| AA= | 00127140 EMBASE No: 96094007 |
| /TI | The importance of the pecan tree pollen in allergic |
| manifestations | |
| AU= | Rachmiel M.; Verleger H.; Waisel Y.; Keynan N.; |
| Kivity S.; Katz Y. | |
| CS= | Pulmonary and Allergy Institute, Assaf-Harofeh |
| Medical Center, Zerifin 70300 Israel | |
| JN=, SO= | Clinical and Experimental Allergy (United Kingdom) , |
| CP=, PY= | 1996 |
| CO= | Vol/Iss/Pg: 26/3 (323-329) CODEN: CLEAE |
| SN= | ISSN: 0954-7894 |
| LA=, SL= | LANGUAGES: English SUMMARY LANGUAGES: English |
| /AB | Background - Pecan tree pollen is considered to be |
| highly allergenic. However, no specific scientific | |
| data about its role in causing allergic diseases are | |
| available. Objective - To study the role of pecan tree | |
| pollen in the development of allergy. Methods - The | |
| presence of pecan tree pollen was determined by weekly | |
| and monthly counting of airborne grains. The incidence | |
| of pecan tree pollen atopy and clinical manifestations | |
| were studied in 395 participants, aged 4-70 years, who | |
| comprised 78.2% of the whole eligible population of a | |
| rural community. The participants were skin tested for | |
| different extracts of allergens, completed detailed | |
| questionnaires, and their medical files were evaluated. | |
| Results - During May, pecan tree pollen grains comprised | |
| 70% of the total airborne grains. A positive skin-prick | |
| test (SPT) to pecan was shown by 46 (11.6%) | |
| participants, constituting 25.4% of the atopic | |
| population. Of those who were found atopic to one or more | |
| allergens 50.3% had symptoms, whereas the parallel figure | |
| for those atopic to pecan pollen was 76.1% (P < 0.005); | |
| 58.7% of the pecan atopic participants had hay fever, | |
| 43.5% had asthma, and 31.5% had both hay fever | |
| and asthma. Among pecan atopic participants the incidence | |
| of hay fever increased with age (P = 0.05), while the | |
| incidence of bronchial asthma, as a sole manifestation of | |
| allergy, decreased in the >17-year-old age group | |
| (P < 0.01). Of the pecan atopics 65.2% had clinical | |
| symptoms coinciding only with the pecan pollen season | |
| and an additional 10.9% had perennial symptoms. | |
| Conclusion - Pecan tree releases highly allergenic | |
| pollen grains, which are correlated to the | |
| incidence of hay fever in the exposed population. The | |
| contribution of pecan tree pollen to the symptoms was | |
| highly significant after discounting olive and cypress | |
| trees that also pollinate in the spring. In | |
| children, the pecan tree constitutes a possible etiologic | |
| agent for the development of asthma. | |
| AUTHOR KEYWORDS: Asthma; Atopy; Cypress; Hay fever; | |
| /ID | Olive; Pecan; Pollen |
| DT= | DOCUMENT TYPE: Article |
| SEARCH SUFFIX |
DISPLAY CODE |
FIELD NAME |
INDEXING |
SELECT EXAMPLES |
|---|---|---|---|---|
| None | None | All Basic Index Fields | Word | S PECAN(W)TREE(W)POLLEN |
| /AB | AB | Abstract1 | Word | S ALLERGIC(W)DISEASE?/AB |
| /ID | ID | Author-Supplied Keywords1,2,3 | Word & Phrase |
S ASTHMA/ID S HAY FEVER/ID |
| /TI | TI | English Title or Original Non-English Title | Word | S PECAN(W)TREE(W)POLLEN/TI |
1 Not present in every record.
| SEARCH PREFIX |
DISPLAY CODE |
FIELD NAME |
INDEXING |
SELECT EXAMPLES |
|---|---|---|---|---|
| AA= | AA | EMBASE ID Number | Phrase | S AA=96094007 |
| None | AN | DIALOG Accession Number | ||
| AU= | AU | Author | Phrase | S AU=RACHMIEL M. |
| CO= | CO | CODEN | Phrase | S CO=CLAE |
| CP= | CP | Country of Publication | Word & Phrase |
S CP=(UNITED(W)KINGDOM) S CP=UNITED KINGDOM |
| CS= | CS | Corporate Source | Word | S CS=(ASSAF(W)HAROFEH(W)MEDICAL) |
| DT= | DT | Document Type | Phrase | S DT=ARTICLE |
| II= | II | Publisher Item Identifier (PII) | Phrase | S II=S0002786396001059 |
| JN= | JN | Journal Name | Phrase | S JN=CLINICAL AND EXPERIMENTAL ALLERGY S JN=CLIN.EXP.ALLERGY |
| LA= | LA | Language | Phrase | S LA=ENGLISH |
| NO= | NO | Article Number | Phrase | S NO=ACI33-99 |
| PY= | PY | Publication Year | Phrase | S PY=1996 |
| SL= | SL | Summary Language | Phrase | S SL=ENGLISH |
| SN= | SN | International Standard Serial Number (ISSN) | Phrase | S SN=0954-7894 |
| SO= | SO | Source Information | Word | S SO=(EXPERIMENTAL(W)ALLERGY AND 323) |
| UD= | None | Update | Phrase | S UD=9999 |
| None | VO | Volume/Issue/Page Numbers |
| Sets and terms can be limited by Basic Index suffixes, i.e., /AB, /ID, /IF, /KW, and /TI (e.g., S S2/TI), as well as by the following features: | ||
| SUFFIX | FIELD NAME | EXAMPLES |
|---|---|---|
| / | DIALOG Accession Number | S S3/00100000-99999999 |
| /ABS | Abstract Present | S S2/ABS |
| /ENG | English Language | S S2/ENG |
| /NOABS | No Abstract Present | S S2/NOABS |
| /NOENG | Non-English Language | S S2/NONENG |
| /YYYY | Publication Year | S S2/1996 |
| SORTABLE FIELDS | EXAMPLES |
|---|---|
| AU, CS, JN, PY, TI | SORT S1/ALL/AU PRINT S5/9/ALL/JN/PY,D |
| RANK FIELDS | EXAMPLES |
|---|---|
| All phrase- and numeric-indexed fields in the Additional Indexes can be ranked. Other RANK codes include: ID | RANK ID RANK AU S4 |
| Display codes listed in the Search Options tables can be used to customize output. | TYPE S3/TI,ID/1-5 |
| NO. |
DIALOGWEB FORMAT |
RECORD CONTENT |
|---|---|---|
| 1 | -- | DIALOG Accession Number |
| 2 | -- | Full Record except Abstract |
| 3 | Medium | Bibliographic Citation |
| 4 | -- | Full Record with Tagged Fields1 |
| 5 | -- | Full Record1 |
| 6 | Free | Title |
| 7 | Long | Bibliographic Citation and Abstract1 |
| 8 | Short | Title |
| 9 | Full | Full Record1 |
| K | -- | KWIC (Key Word In Context) displays a window of text; may be used alone or with other formats |
| FIELD NAME | EXAMPLES | ||
|---|---|---|---|
| If the accession number of a specific record is known, it can be used to display the record directly. | TYPE 00127140/9 DISPLAY 00100169/TI,AU PRINT 00114567/7 |
||
Add RSS
Rates For File: EMBASE® Alert[172]
Cost per DialUnit: $12.85
Cost per minute: $2.61
Rank Elements $0.00
ALERT (default) $7.25
ALERT (Monthly) * $47.50
ALERT (Biweekly/twice a month) * $40.30
ALERT (Weekly) $32.85
ALERT (Daily) $7.25
ALERT (Calendar weekly) * $32.85
ALERT (Intraday) * $7.25
* = custom scheduled Alerts only
ALERT Number of included prints 20
Format Types Prints
1 $0.00 $0.00
2 $4.15 $4.15
3 $4.15 $4.15
4 $4.15 $4.15
5 $4.15 $4.15
6 $0.00 $0.00
7 $4.15 $4.15
8 $0.00 $0.00
9 $4.15 $4.15
KWIC95 $0.42 NA
KWIC96 $0.42 NA
REDIST/COPY Multiplier Table:
Range Multiplier
1-2 1.00
3-25 1.50
26-100 3.00
101-200 4.00
201-500 6.00
501-1000 8.00
1001 or more 10.00
ARCHIVE Multiplier Table:
Range Multiplier
1-25 1.50
26-200 3.00
201-500 6.00
501-1000 8.00
1001 or more 10.00
